However, the selective pressure exerted by chronic p53 activation in IBMFS patients may favor the emergence of cells with p53 mutations or cells that have developed mechanisms to bypass p53-mediated growth arrest [121,122]. Here, TP53 is linked to inherited bone marrow failure syndrome.